Identification of Vyvanse:

No description

Search images on Google      Product Monograph

Active Ingredients:

• lisdexamfetamine dimesylate, 20 MG

DIN: 02490234

Dosage Form(s): TABLET (CHEWABLE)

Route(s) of Administration: ORAL

Schedule: Schedule G (CDSA I)

Company: TAKEDA CANADA INC  –  official site

ATC:

• N06 - PSYCHOANALEPTICS (ATC, WHO, Wiki)
• N06B - PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, WHO)
• N06BA - Centrally acting sympathomimetics (ATC, WHO)
• N06BA12 - LISDEXAMFETAMINE (WHO)

Reference brand drug: Vyvanse

 

External Links for Vyvanse:

Search on Google

• Vyvanse side effects
• Vyvanse dosage
• lisdexamfetamine dimesylate side effects
• lisdexamfetamine dimesylate dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find vyvanse photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.